Expertise in
1
conditions

Paul Meijnders

Antwerpen, VLG, BE 
Expertise in
1
conditions
Antwerpen, VLG, BE 

Overview

Paul Meijnders practices practicing medicine in Antwerpen, Belgium.

Mr. Meijnders is highly rated in 1 condition, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Breast Cancer, Prostate Cancer, and Bone Tumor.

He is actively involved in clinical research, co-authoring 33 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Antwerpen, VLG, Belgium
Other Locations
Wilrijk, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III Trial of Marizomib in Combination With Standard Temozolomide-based Radiochemotherapy Versus Standard Temozolomide-based Radiochemotherapy Alone in Patients With Newly Diagnosed Glioblastoma
A Phase III Trial of Marizomib in Combination With Standard Temozolomide-based Radiochemotherapy Versus Standard Temozolomide-based Radiochemotherapy Alone in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Completed
Publish Date: July 01, 2025
Intervention Type: Drug, Radiation
Study Drugs: Marizomib, Temozolomide
Study Phase: Phase 3
IDH Mutated 1p/19q Intact Lower Grade Glioma Following Resection: Wait Or Treat? IWOT - a Phase III Study
IDH Mutated 1p/19q Intact Lower Grade Glioma Following Resection: Wait Or Treat? IWOT - a Phase III Study
Enrollment Status: Terminated
Publish Date: February 01, 2022
Intervention Type: Radiation, Drug, Procedure
Study Drug: Temozolomide
Study Phase: Phase 3
View 1 Less Clinical Trial

33 Total Publications

FLASH radiation therapy mitigates immunogenic and pro-fibrotic transcriptomic responses in healthy lung tissue.
FLASH radiation therapy mitigates immunogenic and pro-fibrotic transcriptomic responses in healthy lung tissue.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 22, 2026

Frequently Asked Questions about Paul Meijnders

Is Paul Meijnders a top-rated expert for Hodgkin Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Paul Meijnders is classified as an Advanced expert for Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Paul Meijnders participate in research or clinical trials?

Yes. Paul Meijnders has published 33 articles and abstracts on conditions like Hodgkin Lymphoma. You can view a list of Paul Meijnders's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Meijnders's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile